packageNedosiran

nedosiran

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nedosiran is a small interfering RNA medication used to treat primary hyperoxaluria. It is an approved prescription drug, though it does not appear to be authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q123420884 and the WHO ATC classification; not checked by a person.

name:nedosiran
ATC codes:A16AX25
DrugBank:DB17635
Wikidata:Q123420884

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown